Literature DB >> 20381374

Testosterone deficiency: a risk factor for cardiovascular disease?

T H Jones1.   

Abstract

Male gender is a major risk factor for premature cardiovascular death, a relationship not yet explained. Low testosterone in men is a risk factor for the metabolic syndrome and type 2 diabetes and is associated independently with individual components of the metabolic syndrome--visceral obesity, insulin resistance, hyperglycemia, hypertension and dyslipidemia. Epidemiological studies report increased mortality in men with low testosterone. Testosterone replacement in the short-term reduces waist circumference, cholesterol and circulating pro-inflammatory cytokines and improves insulin sensitivity and glycemic control in diabetics. Testosterone also has beneficial effects on cardiac ischemia, angina and chronic heart failure. This manuscript reviews the current evidence supporting a link between low testosterone and cardiovascular disease, highlighting the need for larger, longer-term studies. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381374     DOI: 10.1016/j.tem.2010.03.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  47 in total

1.  Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care.

Authors:  Elisa Martín-Merino; Saga Johansson; Thomas Morris; Luis A García Rodríguez
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

2.  Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.

Authors:  Yu-si Cheng; De-zai Dai; Hui Ji; Qi Zhang; Yin Dai
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

3.  Beneficial Effects of Yoga Stretching on Salivary Stress Hormones and Parasympathetic Nerve Activity.

Authors:  Nobuhiko Eda; Hironaga Ito; Takao Akama
Journal:  J Sports Sci Med       Date:  2020-11-19       Impact factor: 2.988

Review 4.  Testosterone Therapy Among Prostate Cancer Survivors.

Authors:  Taylor M Nguyen; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-07-27

Review 5.  Testosterone in men with hypogonadism and high cardiovascular risk, Pros.

Authors:  Giuseppe M C Rosano; Cristiana Vitale; Massimo Fini
Journal:  Endocrine       Date:  2015-03-07       Impact factor: 3.633

6.  A Comparative Study of Lipid Profile and Cardiovascular Risk Biomarkers Among Chronic Haemodialysis Patients and Healthy Individuals.

Authors:  Shanmugam Lokesh; Tony Mathew Kadavanu; Siva Ranganathan Green; Tarun Kumar Dutta; Radhakrishnan Hemachandar; Arun Kumar Ramachandrappa; Shashank Rakesh Tiwari; Ezhumalai Govindasamy
Journal:  J Clin Diagn Res       Date:  2016-09-01

7.  No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial.

Authors:  E J Giltay; J M Geleijnse; A C Heijboer; J de Goede; L M Oude Griep; M A Blankenstein; D Kromhout
Journal:  Int J Androl       Date:  2012-03-06

8.  Testosterone and the metabolic syndrome.

Authors:  Vakkat Muraleedharan; T Hugh Jones
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

9.  Testosterone and insulin resistance in the metabolic syndrome and T2DM in men.

Authors:  Preethi M Rao; Daniel M Kelly; T Hugh Jones
Journal:  Nat Rev Endocrinol       Date:  2013-06-25       Impact factor: 43.330

Review 10.  Sex and gender differences in myocarditis and dilated cardiomyopathy.

Authors:  DeLisa Fairweather; Leslie T Cooper; Lori A Blauwet
Journal:  Curr Probl Cardiol       Date:  2013-01       Impact factor: 5.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.